{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-062300","form_type":"8-K","ticker":"EMMA","cik":"0000822370","company_name":"Emmaus Life Sciences, Inc.","filed_at":"2022-10-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.659599+00:00","generated_at":"2026-06-23T05:14:54.094487+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Emmaus Life Sciences appoints Ian Zwicker and Dr. Seah Lim to Board; Lim loans $1.2M","bullets":["Ian Zwicker appointed to Board and as Chair of Audit Committee; will receive $25,000 for audit committee service.","Dr. Seah Lim appointed to fill Board vacancy; brings expertise in hematology, oncology, and sickle cell disease.","Dr. Lim loaned Emmaus $1.2M at 6% interest, due in 3 years, with one restricted share per $5 principal.","Loan proceeds used to augment working capital and for general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-062300","json":"https://secwatch.observer/filing/0001213900-22-062300.json","markdown":"https://secwatch.observer/filing/0001213900-22-062300.md","text":"https://secwatch.observer/filing/0001213900-22-062300.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/822370/000121390022062300/0001213900-22-062300-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/822370/000121390022062300/ea166525-8k_emmauslife.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T05:14:54.094487+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4a503e84fc","claim":"Ian Zwicker was appointed as Director and Chair of Audit Committee at Emmaus Life Sciences, Inc..","evidence_excerpt":"the Board appointed Ian Zwicker as a director of the company and as the Chair and sole member of the Audit Committee","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/822370/000121390022062300/0001213900-22-062300-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director and Chair of Audit Committee"}],"fact_type":"executive_change"},{"claim_id":"c0e1a46ca9","claim":"Seah H. Lim was appointed as Director at Emmaus Life Sciences, Inc..","evidence_excerpt":"The Board also appointed Seah H. Lim, M.D., Ph.D. as a director to fill a vacancy on the five-person Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/822370/000121390022062300/0001213900-22-062300-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}